This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: University of Utah Research Foundation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Rob MacLeod: Innovator in Atrial Fibrillation Treatment
Rob MacLeod is a notable inventor based in Salt Lake City, UT, recognized for his contributions to the medical field, particularly in the treatment of atrial fibrillation. His innovative approach combines advanced imaging techniques with clinical assessment to enhance patient outcomes.
Latest Patents
Rob MacLeod holds a patent for "Systems and methods for administering treatment of atrial fibrillation." This patent outlines methods and systems aimed at treating atrial fibrillation. The invention includes methods for assessing the risk of thromboembolic stroke in patients. By acquiring image data, the system determines an indicator of the degree of fibrosis of a patient's left atrium (LA). Based on this analysis, a suitable treatment modality is identified and administered, showcasing the integration of technology in medical applications.
Career Highlights
MacLeod currently works with the University of Utah Research Foundation, where his research focuses on developing innovative medical technologies. His work emphasizes the importance of precision medicine, aiming to personalize treatment for atrial fibrillation patients. His dedication to improving cardiac care through technology has garnered recognition in both clinical and academic circles.
Collaborations
Throughout his career, Rob MacLeod has collaborated with esteemed professionals such as Nassir F. Marrouche and Evgueni Kholmovski. These partnerships underscore the collaborative nature of research and development in medical technologies, contributing to significant advancements in patient care.
Conclusion
Rob MacLeod stands out as an influential figure in the realm of cardiac health innovations. With a focus on the intersection of technology and medicine, his contributions pave the way for improved treatments of atrial fibrillation. His patent reflects a commitment to enhancing patient outcomes, and his collaborations with other experts highlight the importance of teamwork in driving healthcare innovations forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile